This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.
Deciphering phosphorylation-dependent signal rewiring in ovarian and endometrial cancer
Metabolic Gene-Edited CAR-T Cells For Ovarian Cancer Treatment
Metabolic engineering of CAR-T cells to overcome immune suppression
Remodeling the immune microenvironment of ovarian cancer using oncolytic viruses
Understanding how glycosylated antitumour ether lipids (GAELs) kill chemotherapy-resistant cancer cells
Investigating the “surfaceome” to discover new treatments for rare ovarian cancers
Understanding and targeting single-stranded DNA gap-filling mechanisms to improve chemotherapy response
Exploring a new therapeutic approach for rare ovarian cancers
Investigating how a novel glycolipid drug kills chemotherapy-resistant ovarian cancer
A new approach to sustained, local, immunotherapy for ovarian cancer
